We are live on ! Find out more
PWM

Perigon Wealth Management Portfolio holdings

AUM $5.51B
1-Year Est. Return 24.51%
This Fund
S&P 500
This Quarter Est. Return
-2.95%
1 Year Est. Return
+24.51%
3 Year Est. Return
+81.31%
5 Year Est. Return
+97.59%
10 Year Est. Return
+364.46%
AUM
$1.42B
AUM Growth
+$17.1M
Cap. Flow
+$83.9M
Cap. Flow %
5.92%
Top 10 Hldgs %
32.49%
Holding
657
New
81
Increased
315
Reduced
168
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 20.42%
2 Industrials 10.11%
3 Financials 7.18%
4 Healthcare 6.43%
5 Consumer Discretionary 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
U icon
651
Unity
U
$13.4B
-1,564
Closed -$224K
URI icon
652
United Rentals
URI
$70.1B
-718
Closed -$239K
ZS icon
653
Zscaler
ZS
$24.1B
-653
Closed -$210K
NUAN
654
DELISTED
Nuance Communications, Inc.
NUAN
-6,700
Closed -$371K
XLNX
655
DELISTED
Xilinx Inc
XLNX
-9,531
Closed -$2.02M
RDS.B
656
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
-11,332
Closed -$491K
FCCY
657
DELISTED
1st Constitution Bancorp
FCCY
-11,443
Closed -$293K

Similar funds

Perigon Wealth Management's Q1 2022 Portfolio in Review

As of Q1 2022, Perigon Wealth Management held 657 positions worth $1.42B, up 1.2% from $1.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Perigon Wealth Management deployed $83.9M of net new capital in Q1 2022, opening 81 new positions and adding to 315 existing holdings. Its largest new stake was Core Scientific, Inc. Common Stock: 1,763,255 shares worth $14.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was 4D Molecular Therapeutics, an estimated $3.29M trimmed.

  • Perigon Wealth Management's largest Q1 2022 buy was Core Scientific, Inc. Common Stock: 1,763,255 shares worth $14.5M.
  • Perigon Wealth Management added most to Salesforce in Q1 2022, an estimated $12M increase.
  • Perigon Wealth Management's biggest Q1 2022 reduction was 4D Molecular Therapeutics, cutting an estimated $3.29M.
  • Perigon Wealth Management fully exited Xilinx Inc in Q1 2022, selling an estimated $2.02M.
  • Perigon Wealth Management's ten largest holdings make up 32% of its $1.42B portfolio in Q1 2022.
  • Perigon Wealth Management opened 81 new positions and closed 58 in Q1 2022.
  • Perigon Wealth Management's portfolio value rose 1.2% quarter-over-quarter to $1.42B.

Based on Perigon Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.